| 生物活性 | |||
|---|---|---|---|
| 描述 | PQM130, a Feruloyl-Donepezil brain injury hybrid, is a multi-target drug candidate that fights neurotoxicity caused by Aβ1-42 oligomers (AβO) and has anti-inflammatory activity. PQM130 is a neuroprotective compound developed as an anti-AD drug[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.62mL 0.52mL 0.26mL |
13.11mL 2.62mL 1.31mL |
26.22mL 5.24mL 2.62mL |
| 参考文献 |
|---|